SII, Bharat Biotech seek hike in government price for Covid vaccines
Serum Institute of India (SII) and Bharat Biotech (BB) are seeking higher prices for Covid-19 vaccines from the Centre amid concerns that the cost of Covishield and Covaxin shots in private hospitals is already high. The Centre’s procurement price has been in the range of Rs 150-200 per jab, for the orders placed with the companies from January onwards.
💡 newsR Knowledge: Other News Mentions
Sputnik V vaccine production in India to go fully on stream in September: RDIFThe production of Sputnik V in India is expected to come fully on stream in September. "Production in India is expected to come fully onstream in September and..
Health Ministry: '3rd wave predictions treated casually like weather forecast' | Oneindia News
Credit: Oneindia Duration: 02:37Published
India's Covidshield wins: 7 European Nations and Switzerland give a green signal| Covid19 | Oneindia
Credit: Oneindia Duration: 02:02Published
SII's request to conduct Covovax trial on children reportedly denied by CDSCO | Oneindia News
Credit: Oneindia Duration: 01:31Published
Covishield cleared by 7 EU nations, Switzerland for travellers amid row | Oneindia News
Credit: Oneindia Duration: 02:47Published
Covaxin output set to rise; govt hopes to meet 135 crore-dose goalIndian Immunologicals Limited is likely to start supply of an additional 2 million doses of Covaxin from August-September, whereas Bharat Biotech’s Ankleshwar..
Brazil's Anvisa provisionally suspends authorisation for exceptional import of 4 million Covaxin dosesAfter closing the emergency use authorisation (EUA) and Phase-3 clinical trials requests for Bharat Biotech’s Covaxin, Brazil’s health regulator Anvisa..
After suspending Covaxin clinical trials, Brazil closes EUA requestAfter suspending the clinical trials of Covaxin following the termination of Bharat Biotech's MoU with its Brazilian partner Precisa Medicamentos, Brazil’s..
PM Modi cut off by opposition’s slogans: First day of Parliament's Monsoon Session | Oneindia News
Credit: Oneindia Duration: 02:22Published
Credit: FRANCE 24 English Duration: 02:38Published
WHO calls for COVID booster jab moratorium to accelerate vaccination in poorer countries
Credit: Euronews English Duration: 01:59Published
Covid-19: India records 42,982 new cases, 533 deaths in last 24 hoursIndia saw a single day rise of 42,982 new coronavirus infections taking the total tally of Covid-19 cases to 3,18,12,114, while the active cases increased to..
COVID-19 travel advisory: UK to move India from' Red list' to 'Amber list', know new rules"India will move to the amber list 4 am, Sunday 8 August (local time)," the UK government said.
COVID-19: Delhi government revises rates for RT-PCR, Rapid Antigen Tests, check new pricesAs per the revised rates, both the RT-PCR test and RAT will now cost Rs 300 in Delhi when samples are collected by teams sent by the government.
Creator of Oxford vaccine made into Barbie doll
Credit: PA - Press Association STUDIO Duration: 01:07Published
Rahul Gandhi on nine-year-old girl's rape: Dalit child nation's daughter too| Oneindia News
Credit: Oneindia Duration: 03:00Published
CDSCO expert panel recommends nod to study on mixing doses of Covaxin, CovishieldAn expert panel of India's central drug authority on Thursday recommended granting permission to the Christian Medical College (CMC) in Vellore for conducting a..
Covishield generates 93% protection, says AFMC studyCovishield generated 93% protection against Covid, whereas mortality due to the infection came down by 98% during the second wave which was driven by Delta..
Covishield reduces fresh infections by 93%, deaths by 98%: AFMS studyA study by Armed Forces Medical Services (AFMS) has found that Covishield vaccine reduces fresh COVID-19 infections by 93 per cent and deaths by 98 per cent, the..
You Might Like
Related videos from verified sources
Related news from verified sources